Karyo Biologics
Pharmaceuticals - Hoffman Estates, Illinois, United States
Karyo Biologics Employees
Karyo Biologics Details
Karyo Biologics (KBL) is a "fast to market" developer and licensor of biosimilar drugs. Utilizing the Niazi Technology and KBL business model, KBL significantly reduces time and cost resulting in $0 of capital, becoming the first private label supplier, and providing an effective regulatory approval.KBL has a very experienced and diverse leadership team allowing for unique collaborative agreements with commercial suppliers and supply partners. Managed risks support the lean and effective busniess model allowing for significant time reduction and increased returns. KBL has successfully reduced the biosimlar time to market by 37% and expenses by 20%.Dr. Sarfaraz Niazi, Chairman & CSO, is a pioneer in the biosimilar field recognized for being the largest solo inventor of bioprocessing technology in the World. He founded Therapeutic Proteins, Inc (now Adello Biologics) and is known as a well established author writing the largest number of books in the field of pharmaceutical formulation and manufacturing , bioprocessing and biosimilars. Dr. Nizai has an established relationship with the Food and Drug Administration (FDA) further reducing time and cost related to regulatory approval.
Karyo Biologics Technologies
Email Providers
Gmail
Domain Name Services
NSOne
Other
Google Apps